Similar articles

• What if technology never stops improving? Medicare's future under continuous cost increases.

  Pauly MV. Pauly MV. Spec Law Dig Health Care Law. 2004 Dec;(308):9-26. Spec Law Dig Health Care Law. 2004. PMID: 15693440 No abstract available.
• Coverage options for promising technologies: Medicare's 'coverage with evidence development'.

  Tunis SR, Pearson SD. Tunis SR, et al. Health Aff (Millwood). 2006 Sep-Oct;25(5):1218-30. doi: 10.1377/hlthaff.25.5.1218. Health Aff (Millwood). 2006. PMID: 16966717
• Medicare's coverage of colorectal cancer drugs: a case study in evidence development and policy.

  Carino T, Williams RD 2nd, Colbert AM, Bridger P. Carino T, et al. Health Aff (Millwood). 2006 Sep-Oct;25(5):1231-9. doi: 10.1377/hlthaff.25.5.1231. Health Aff (Millwood). 2006. PMID: 16966718
• Getting involved: my experience with Medicare's Advisory Panel on APC Groups.

  Francis DL. Francis DL. Clin Gastroenterol Hepatol. 2011 May;9(5):392-4. doi: 10.1016/j.cgh.2011.01.025. Clin Gastroenterol Hepatol. 2011. PMID: 21513893 Review. No abstract available.
• A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.

  Wallner PE, Konski A. Wallner PE, et al. J Am Coll Radiol. 2008 Nov;5(11):1125-9. doi: 10.1016/j.jacr.2008.06.008. J Am Coll Radiol. 2008. PMID: 18954812 Review.